1Redfield R R, Just M, et al. A Phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. New Engl J Med, 1991,324:1677
2Vitiello A, Ishilka G, Grey H M, et al.Development of a lipopeptide based therapeutic vaccine to treat chronic HBV infection. J Clin Invest, 1995,95:341.
3Ishioka GY, Fikes J, Hermanson G, et al.Utilization of MHC class I transgenic mice for developent of minigene DNA vaccines encoding multiple HLA restricted CTL epitopes. J Immunol 1999,162(7):3915-3925.
4Ayed M, Ben Hassine L, Ben Siama R, et al.Results of BCG in sthe treatment of pTa and pT1bladder tumors:Evaluation of a long protocol using 75mg of Pasteur strain BCG. Prog Urol,1998(8):206-210.
